Page last updated: 2024-10-26

famotidine and Stevens-Johnson Syndrome

famotidine has been researched along with Stevens-Johnson Syndrome in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheinfeld, N1
Wesson, K1
Perry, P1
Weinberg, J1
Brunner, M1
Vardarman, E1
Goldermann, R1
Goerz, G1
Niederau, D1
Merk, HF1
Scharffetter-Kochanek, K1

Other Studies

2 other studies available for famotidine and Stevens-Johnson Syndrome

ArticleYear
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
    Acta dermato-venereologica, 2003, Volume: 83, Issue:1

    Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu

2003
Toxic epidermal necrolysis (Lyell syndrome) following famotidine administration.
    The British journal of dermatology, 1995, Volume: 133, Issue:5

    Topics: Adult; Famotidine; Histamine H2 Antagonists; Humans; Male; Stevens-Johnson Syndrome

1995